# IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update

- Source: PR Newswire General Business
- Published: 2026-11-03T11:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/ideaya-biosciences-reports-financial-results-for-the-third-quarter-2026-and-provides-a-business-update-302926978.html
- Canonical: https://groundlevelnews.com/story/ideaya-biosciences-reports-financial-results-for-the-third-quarter-202-d9d2ca/

Data presented at ESMO 2026 collectively supports the potential of darovasertib to become a foundational new therapy across the treatment journey of uveal melanoma in both primary and metastatic disease, irrespective of HLA-A*02:01 allele status or line of therapy Completed NDA submission...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire General Business._